|
Additional information - this emdr is being submitted to include the below: h3: device evaluated by mfg.H6 - investigation results under imdrf cause investigation code, imdrf investigation findings, imdrf cause conclusions.A batch record review was completed, and no discrepancies were found.All in-process stat sample quality checks were satisfactory.The first piece devices taken from the batch does not show evidence of staining.Aquacel foam ag n/adh10x10(1x10) nai was manufactured under (b)(4) and manufacturing lot number 1k03931 on 30 october 2021.Lot # 1k03931 was sterilised under reference order (b)(4) and released on review of results of sterilisation provided by sterilisation company sterigenics.All of the results were within specification and products were released.No nonconformity was identified during the manufacturing process of lot 1k03931.This is the only complaint for the affected lot registered within database.One photograph was received for this issue and has been evaluated in accordance with work instruction (wi).The photograph confirms the expected product and the complaint issue where staining can be seen on packaging.The sample for the complaint was requested on 20th september 2022 and received on 3rd october 2022.An nc (non-conformance) was opened for this issue for stain on primary packaging.Upon receiving the complaint sample, the sample was inspected to identify that the staining was not on the primary packaging, but instead the external pink pu (polyurethane) material on the dressing itself.Further investigation confirmed this staining was limited to the external surface of the pink pu, and not the foam or hydrofibre beneath.The pink pu material was provided by an external supplier, (b)(4), and is printed with ¿ag¿ symbology.The supplier was contacted, but confirmed this would have been an isolated issue, but that the printing of this symbology was subcontracted.However, this symbology printing is now completed in-house, so no corrective actions would be necessary for the issue.The pink pu batch was checked to identify it had been used in 8 other final product batches.No complaints have been received for this issue against any of the other 8 batches.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092.Manufacturing site: 1000317571.
|